Phathom Pharmaceuticals, Inc. (PHAT)
NASDAQ: PHAT · Real-Time Price · USD
12.12
+0.92 (8.21%)
May 1, 2026, 10:15 AM EDT - Market open
Phathom Pharmaceuticals Analyst Ratings
Total Analysts
6
Consensus Rating
Strong Buy
Price Target
$19.83
Upside
+63.61%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Hold → Buy Upgrades $16 → $18 | Hold → Buy | Upgrades | $16 → $18 | +48.51% | Mar 27, 2026 |
| Guggenheim | Guggenheim | Strong Buy Maintains $20 → $25 | Strong Buy | Maintains | $20 → $25 | +106.27% | Feb 27, 2026 |
| Barclays | Barclays | Hold Initiates $16 | Hold | Initiates | $16 | +32.01% | Dec 9, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $20 → $26 | Strong Buy | Maintains | $20 → $26 | +114.52% | Oct 31, 2025 |
| Craig-Hallum | Craig-Hallum | Strong Buy Maintains $12 → $17 | Strong Buy | Maintains | $12 → $17 | +40.26% | Jun 9, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $20 | Strong Buy | Reiterates | $20 | +65.02% | Jun 9, 2025 |
| Needham | Needham | Strong Buy Maintains $28 | Strong Buy | Maintains | $28 | +131.02% | Jun 6, 2025 |
| Craig-Hallum | Craig-Hallum | Strong Buy Maintains $19 → $12 | Strong Buy | Maintains | $19 → $12 | -0.99% | May 2, 2025 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $10 → $5 | Hold | Maintains | $10 → $5 | -58.75% | May 2, 2025 |
| Guggenheim | Guggenheim | Strong Buy Maintains $18 → $12 | Strong Buy | Maintains | $18 → $12 | -0.99% | May 2, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $28 → $20 | Strong Buy | Maintains | $28 → $20 | +65.02% | May 2, 2025 |
| Needham | Needham | Strong Buy Reiterates $28 | Strong Buy | Reiterates | $28 | +131.02% | Apr 21, 2025 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $12 → $10 | Hold | Maintains | $12 → $10 | -17.49% | Apr 17, 2025 |
| Needham | Needham | Strong Buy Reiterates $28 | Strong Buy | Reiterates | $28 | +131.02% | Apr 9, 2025 |
| Guggenheim | Guggenheim | Strong Buy Reiterates n/a | Strong Buy | Reiterates | n/a | n/a | Apr 2, 2025 |
| Needham | Needham | Strong Buy Reiterates $28 | Strong Buy | Reiterates | $28 | +131.02% | Apr 2, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.